Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laure Deramoudt
Observed name:
L. Deramoudt
Institutions:
Université de Lille,
Centre Hospitalier Universitaire de Lille,
Groupe de Recherche sur les formes Injectables et les Technologies Associées
Observed institutions:
Inserm,
Université de Lille,
Centre Hospitalier Universitaire de Lille,
Groupe de Recherche sur les formes Injectables et les Technologies Associées,
Lille Neurosciences & Cognition
ORCID:
0009-0003-4807-9037
Observed ORCID:
0009-0003-4807-9037
OpenAlex ID:
A5043125344
A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion
2022
·
Florent Salvador
, Laure Deramoudt
, et al.
·
Frontiers in Immunology
·
18
Identification of the conditions and minimum requirements necessary for the release of autologous fresh CAR T-cell products under hospital exemption: a position paper from the WP-bioproduction of the UNITC consortium
2025
·
Olivier Boyer
, Daniele Bensoussan
, et al.
·
Bone Marrow Transplantation
·
8
Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacy
2024
·
Laure Deramoudt
, Marine Pinturaud
, et al.
·
Occupational and Environmental Medicine
·
3
PDF
Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanoma
2024
·
Marie Leroy
, Eve Desmedt
, et al.
·
Melanoma Research
·
3
B cells and humoral immunity in demyelinating diseases of the central nervous system
2022
·
Laure Deramoudt
·
theses.fr (ABES)
·
1
Factors influencing interactions between protein-containing drug solutions and containers: A structured, critical review
2026
·
Morgane Masse
, Laure Deramoudt
, et al.
·
Journal of Pharmaceutical Sciences
Comparaison entre une dose poids toutes les deux semaines et une dose fixe de nivolumab tous les mois dans le traitement du mélanome avancé : une analyse en vie réelle
2024
·
M. Leroy
, E. Desmedt
, et al.
·
Le Pharmacien Clinicien
A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off
2024
·
Marie Leroy
, Laure Deramoudt
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Show more works
View as search
Works count:
8
Citation count:
33
H-index:
3
I10-index:
1
Year
Topic
Type